| アブストラクト | BACKGROUND: Amlodipine, a widely prescribed clinical medication, is associated with adverse reactions that can impede the proper execution of treatment regimens. The lack of systematic studies on amlodipine's adverse drug reactions (ADRs) necessitates further investigation to facilitate refined population management and optimize therapeutic outcomes. METHOD: This study leveraged the FDA Adverse Event Reporting System (FAERS) database, extracting reports submitted exclusively by healthcare professionals where amlodipine was designated as the primary suspect (PS). Four risk signal detection methods were employed: Ratio of Odds Ratio, Proportional Reporting Ratio, Bayesian Confidence Propagation Neural Network, and Empirical Bayes Geometric Mean, to conduct a comprehensive analysis of amlodipine-related ADRs. Furthermore, subgroup analyses stratified by gender and age were performed, with multivariable logistic regression utilized to validate the reliability of the findings. RESULTS: Across the general population, male cohort, female cohort, elderly group, and younger demographic, the four signal detection methods collectively identified 513, 348, 403, 246, and 260 potential ADRs associated with amlodipine, respectively. Intersection analysis revealed 27 common ADRs, including gingival hypertrophy, vasoplegia syndrome, and distributive shock. Subsequent multivariable logistic regression confirmed amlodipine's role as an independent risk factor for all 27 ADRs (OR > 1, P < 0.05). CONCLUSION: This study provides compelling evidence that amlodipine poses risks of peripheral edema, shock, and dyspnea, among others. Additionally, it identified previously unreported ADRs such as abnormal full blood count and personality disorder. These findings underscore the importance of exercising caution when prescribing amlodipine to high-risk individuals with a history of hyperkalemia, cardiac structural abnormalities, or airway obstruction. |
|---|
| ジャーナル名 | Frontiers in cardiovascular medicine |
|---|
| Pubmed追加日 | 2025/5/21 |
|---|
| 投稿者 | Jiang, Jiazhen; Zhong, Qian; Zhou, Xinyu; Zhou, Lisi; Zheng, Jiyuan; Liu, Bingshuo; Di, Xingwei |
|---|
| 組織名 | The First Clinical Medical School of Guangzhou University of Chinese Medicine,;Guangzhou, Guangdong, China.;Department of Cardiovascular Medicine, First Affiliated Hospital of Jinzhou;Medical University, Jinzhou, Liaoning, China.;Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation,;Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.;The Fifth Clinical College, Guangzhou University of Chinese Medicine, Guangzhou,;Guangdong, China.;Department of Cardiovascular Medicine, The First Affiliated Hospital of Guangzhou;University of Chinese Medicine, Guangzhou, Guangdong, China. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/40395720/ |
|---|
